Navigation Links
Lo screening trial sul cancro al seno conclude che l'utilizzo della mammografia 3D in combinazione con un esame del seno 2D rileva un numero di tumori significativamente maggiore rispetto al solo esame del seno 2D
Date:1/17/2013

BEDFORD, Massachusetts, 17 gennaio 2013 /PRNewswire/ -- Hologic, Inc. (Hologic o la società) (NASDAQ: HOLX), leader nello sviluppo, nella produzione e nella fornitura di sistemi diagnostici e medici di acquisizione delle immagini e di prodotti chirurgici di alta qualità dedicati al servizio delle esigenze di salute delle donne, ha annunciato il 9 gennaio 2013 che un nuovo studio rivoluzionario, pubblicato su Radiology, la rivista scientifica della Radiological Society of North America, ha riscontrato che l'aggiunta all'esame 2D di screening al seno della tecnologia a tre dimensioni (3D) per la mammografia (tomosintesi al seno) di screening  aumenta in maniera significativa la rilevazione del cancro e riduce il numero di falsi positivi.

Lo studio, "Comparison of Digital Mammography Alone and Digital Mammography plus Tomosynthesis in a Population-based Screening Program" (Confronto della sola mammografia digitale con la mammografia digitale abbinata alla tomosintesi in un programma di screening sulla popolazione), è stato condotto da Per Skaane, M.D., Ph.D. dell'Ospedale Universitario Ullevaal di Oslo. Lo studio è stato basato su 12.631 esami di screening in un grande ospedale norvegese.

I ricercatori hanno riscontrato, mediante la tecnologia Hologic della mammografia 3D di in combinazione con una mammografia 2D, un notevole aumento nei tassi di rilevazione del cancro e una contemporanea diminuzione di falsi positivi rispetto alla sola mammografia 2D. Risultati importanti includono:

  • Un aumento del 40% nella rilevazione di cancri al seno invasivi
  • Un aumento del 27% nella rilevazione di tutti i cancri (invasivi e in situ)
  • Una riduzione del 15% nei falsi positivi

  • Gli autori hanno riferito che l'aumento nella rilevazione de
    '/>"/>

    SOURCE Hologic, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
    2. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
    3. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
    4. Trovagene Announces Plans to Develop Proprietary Test for High Risk HPV Carrier Screening from Urine
    5. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
    6. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
    7. Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening
    8. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
    9. New Study Answers CMS/USPSTF Concerns for CT Colonography Screening Reimbursement: It is a Viable Option for the Medicare-Aged Population
    10. Pulse Oximetry Screening Hailed as the New Milestone to Combat Critical Congenital Heart Disease - Signal Extraction Technology Leading the Way in Large, Independent Clinical Studies
    11. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... CAMBRIDGE, Mass. , Oct. 22, 2014 ... Cambridge, MA is revolutionizing spinal cord ... technique has been shown to outperform in tissue regrowth ... with the scaffold.  Made from an FDA approved polymer, ... dioxide; making it harmless to the human body. NVIV ...
    (Date:10/22/2014)... and AUSTIN, Texas , Oct. ... LLC today announced they have entered into a ... immunotherapies designed to target cancers. PhosImmune ... displayed on the surfaces of tumor cells in ... (PTTs), derived from proteins that play a role ...
    (Date:10/22/2014)... , Oct. 22, 2014  Recently published clinical ... bolstered the already substantial database of evidence. This data ... of Stretta therapy for sufferers of refractory ... clinical evidence supporting Stretta therapy as a safe ... that make Stretta therapy available to nearly 50 million ...
    Breaking Medicine Technology:InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round 2
    ... , July 15 /PRNewswire-Asia-FirstCall/ -- China Medical ... China -based advanced in-vitro,diagnostic ("IVD") company, today announced ... used in a research project focusing on cancer targeted ... which is,sponsored by the Chinese Ministry of Health. One ...
    ... , DALLAS , July 14 After two days ... (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone ... members suggesting that the label be revised to include increased warnings. Rosiglitazone ... treat type 2 diabetes. , , ...
    Cached Medicine Technology:China Medical Technologies Announces the Use of its HER-2 FISH Probe in a Cancer Targeted Therapy Research Project Sponsored by the Chinese Ministry of Health 2China Medical Technologies Announces the Use of its HER-2 FISH Probe in a Cancer Targeted Therapy Research Project Sponsored by the Chinese Ministry of Health 3American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep Rosiglitazone (Avandia) on the Market, Continue Clinical Trial of Safety and Efficacy 2American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep Rosiglitazone (Avandia) on the Market, Continue Clinical Trial of Safety and Efficacy 3American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep Rosiglitazone (Avandia) on the Market, Continue Clinical Trial of Safety and Efficacy 4
    (Date:10/20/2014)... 2014 The newly updated Worldwide Medical ... thousands of facts, figures and forecasts on the global ... sector forecast categories the Worldwide Medical Market Forecasts ... national views on the worldwide medical market to reveal ... gives you data for 2010-2019, covering each country market ...
    (Date:10/20/2014)... (PRWEB) October 20, 2014 Allegheny General ... procedure that enables physicians to repair a damaged mitral ... MitraClip system, developed by Abbott Vascular ... a progressive and life-threatening condition in which the heart’s ... to flow backward from the heart’s left ventricle into ...
    (Date:10/20/2014)... (PRWEB) October 20, 2014 ASCNYC ... organization that helps New Yorkers living with HIV/AIDS ... toward health, housing, recovery and self-sufficiency. Each year, ... the local community through their tireless efforts. , ... Marc Shapses , has been selected as this ...
    (Date:10/20/2014)... October 20, 2014 T.E.N., a ... firm, announced today that William H. Murray, renowned ... 2014 ISE® Luminary Leadership Award winner. Presented annually, ... of an outstanding leader and industry practitioner for ... in advancing the information security industry. , Formerly ...
    (Date:10/20/2014)... October 20, 2014 Zereana Jess-Huff, a 34-year-old ... Maryland 2014 on a platform to think outside the bra. ... uses her position to raise awareness about women’s other lady ... breast cancer. You say the color pink and everybody knows ... for a fact that it has not been won when ...
    Breaking Medicine News(10 mins):Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3
    ... Restrictions should be placed on the use of Ginkgo biloba ... growing scientific evidence that Ginkgo may increase the risk of ... of anti-seizure drugs, a new report concludes. The article appears ... also suggests that Ginkgo may have harmful effects in other ...
    ... polycarbonate plastic source of a huge environmental headache because ... key to disposing of the waste in an eco-friendly way, ... Biomacromolecules , a monthly journal. Mukesh Doble and ... of plastic containing BPA each year. Polycarbonate is an extremely ...
    ... manufacturers are rolling out a new generation of products ... according to an article in the current issue of ... C&EN Assistant Managing Editor Michael McCoy points out ... fabric cleaning products is occurring despite a rocky economy ...
    ... trials will begin soon, researchers say , WEDNESDAY, Jan. ... as a treatment for uterine fibroids, say U.S. researchers ... therapy. , Uterine fibroids, which affect 40 percent of ... fatigue and lack of energy. Currently, hysterectomy is the ...
    ... ... over the world to win the one they want, and ultimately, to win in love. ... Boston, MA (PRWEB) January 27, 2010 -- ... the release of the movie Valentine’s Day, this year even more than ever, there is a ...
    ... A hair ... by the researchers who demonstrated its potential, because it is still in the early stages ... ... hair restoration surgeons Dr Gary Hitzig and Dr Jerry Cooley created a technique that multiplies ...
    Cached Medicine News:Health News:A Different Kind of Valentine's Day Story 2Health News:Hair Cloning Not Yet Recommended by Researchers Who Developed the Technique 2
    Digital Thermometer & High-Low Temp Alarm, -50C to +90C...
    ... The F340 is a basic laboratory ... compensated pH results can be obtained when ... a 3-in-1 electrode. • Fast and easy ... buffer recognition for five buffers (pH 1.68, ...
    ... laboratory system for pH and temperature measurements. ... when used with a temperature probe (ATC) ... easy one and two-point calibration with Auto-Find ... 1.68, 4.00, 7.00, 10.01 and 12.45) and ...
    ... microplate reader combines improved flexibility ... with a wide range of ... the flexibility, sensitivity and high ... is the ideal detection solution ...
    Medicine Products: